Stanley, Thomas B.
GlaxoSmithKline (United States)
3 papers on CoChat
Most cited papers
- Verified
Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator Recognition
Bledsoe, R. K., Montana, V. G., Stanley, T. B., Delves, C. J., Apolito, C. J., McKee, D. D., Consler, T. G., Parks, D. J., Stewart, E. L., Willson, T. M., et al. (2002) · Cell
Estrogen and related hormone effectsReceptor Mechanisms and Signaling
Cited by 818
- Verified
Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity
Atkins, C., Liu, Q., Minthorn, E., Zhang, S.-Y., Figueroa, D. J., Moss, K., Stanley, T. B., Sanders, B., Goetz, A., Gaul, N., et al. (2013) · Cancer Research
Endoplasmic Reticulum Stress and DiseasePI3K/AKT/mTOR signaling in cancer
Cited by 443
- Verified
Identification and Characterization of 4-Chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a Selective and Irreversible Peroxisome Proliferator-Activated Receptor δ (PPARδ) Antagonist
Shearer, B. G., Wiethe, R. W., Ashe, A., Billin, A. N., Way, J. M., Stanley, T. B., Wagner, C. D., Xu, R. X., Leesnitzer, L. M., Merrihew, R. V., et al. (2010) · Journal of Medicinal Chemistry
Peroxisome Proliferator-Activated ReceptorsComputational Drug Discovery Methods
Cited by 78
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free